BE823064A - Procede de preparation de peptides - Google Patents
Procede de preparation de peptidesInfo
- Publication number
- BE823064A BE823064A BE151258A BE151258A BE823064A BE 823064 A BE823064 A BE 823064A BE 151258 A BE151258 A BE 151258A BE 151258 A BE151258 A BE 151258A BE 823064 A BE823064 A BE 823064A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation process
- peptides preparation
- peptides
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2360794A DE2360794C2 (de) | 1973-12-06 | 1973-12-06 | Verfahren zur Herstellung von Peptiden |
Publications (1)
Publication Number | Publication Date |
---|---|
BE823064A true BE823064A (fr) | 1975-06-06 |
Family
ID=5900062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE151258A BE823064A (fr) | 1973-12-06 | 1974-12-06 | Procede de preparation de peptides |
Country Status (12)
Country | Link |
---|---|
US (1) | US3960830A (fr) |
JP (1) | JPS5088003A (fr) |
BE (1) | BE823064A (fr) |
CH (1) | CH605679A5 (fr) |
DE (1) | DE2360794C2 (fr) |
DK (1) | DK633374A (fr) |
FR (1) | FR2253736B1 (fr) |
GB (1) | GB1464938A (fr) |
IE (1) | IE40281B1 (fr) |
LU (1) | LU71415A1 (fr) |
NL (1) | NL7415602A (fr) |
SE (1) | SE7415305L (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH611878A5 (fr) * | 1974-07-04 | 1979-06-29 | Takeda Chemical Industries Ltd | |
DE2930542A1 (de) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | Neue insulinderivate und verfahren zu ihrer herstellung |
US4585757A (en) * | 1984-07-27 | 1986-04-29 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
JPH0520266U (ja) * | 1991-01-31 | 1993-03-12 | 松下電器産業株式会社 | 電気部品の接続装置 |
EP0536671B1 (fr) * | 1991-10-07 | 1996-03-06 | Hoechst Aktiengesellschaft | Groupes de protection ester d'acides carboxyliques, procédé pour les synthétiser, leur couplage à un groupe fonctionnel et leur utilisation |
US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US7883693B2 (en) | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
JP4193917B2 (ja) * | 1995-12-18 | 2008-12-10 | アンジオデバイス インターナショナル ゲーエムベーハー | 架橋ポリマー組成物およびその使用方法 |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
DK1400551T3 (da) | 1998-08-28 | 2007-10-15 | Amylin Pharmaceuticals Inc | Polyamidkæder med præcis længde og deres konjugater med proteiner |
LT2599503T (lt) * | 1998-10-16 | 2017-06-26 | Biogen Ma Inc. | Interferono beta-1a polimero konjugatai ir jų panaudojimas |
EP1300418A1 (fr) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Régulation génétique par des oligopeptides |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
EP1594459B1 (fr) | 2002-12-30 | 2010-02-17 | Angiotech International Ag | Liberation de medicaments a partir d'une composition polymere a gelification rapide |
JP2006519766A (ja) * | 2002-12-30 | 2006-08-31 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 組織反応性化合物および組成物、ならびにそれらの使用法 |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
WO2006083260A2 (fr) | 2004-04-28 | 2006-08-10 | Angiotech Biomaterials Corporation | Compositions et systemes pour la formation de biomateriaux reticules et procedes associes de preparation et d'utilisation |
CA2579790A1 (fr) * | 2004-07-30 | 2006-02-09 | Mount Sinai School Of Medicine Of New York University | Inhibiteurs de npc1l1 et npc1l1 et procedes d'utilisation associes |
CA2581093C (fr) | 2004-09-17 | 2014-11-18 | Angiotech Biomaterials Corporation | Composes multifonctionels pour la formation de biomateriaux reticules et leurs procedes de preparation et d'utilisation |
WO2007034812A1 (fr) * | 2005-09-20 | 2007-03-29 | National University Corporation, Tokyo University Of Agriculture And Technology | Support de séparation, procédé de séparation d’un composé et procédé de synthèse de peptide utilisant le support |
EP1864692A1 (fr) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Utilisation de peptides pour la protection contre les radiolésions |
NZ578956A (en) * | 2007-02-12 | 2012-02-24 | Biotempt Bv | Treatment of trauma hemorrhage with short oligopeptides |
US9051349B2 (en) | 2007-11-21 | 2015-06-09 | Alba Therapeutics Corporation | Larazotide acetate compositions |
EP2062909A1 (fr) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Production de peptides et procédé de purification |
CA2748340C (fr) | 2008-12-29 | 2017-01-24 | Trevena, Inc. | Effecteurs de la .beta.-arrestine, compositions en contenant et leurs procedes d'utilisation |
US9518086B2 (en) * | 2014-02-07 | 2016-12-13 | Trevena, Inc. | Crystalline and amorphous forms of a β-arrestin effector |
AU2015264367A1 (en) | 2014-05-19 | 2016-12-15 | Trevena, Inc. | Synthesis of Beta-Arrestin Effectors |
WO2016011037A1 (fr) * | 2014-07-14 | 2016-01-21 | Peg Biosciences, Inc. | Promédicaments d'enképhaline polymères |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE337223B (fr) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3502545A (en) * | 1968-09-27 | 1970-03-24 | Monsanto Co | Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel |
-
1973
- 1973-12-06 DE DE2360794A patent/DE2360794C2/de not_active Expired
-
1974
- 1974-11-29 NL NL7415602A patent/NL7415602A/xx unknown
- 1974-12-04 LU LU71415A patent/LU71415A1/xx unknown
- 1974-12-04 US US05/529,519 patent/US3960830A/en not_active Expired - Lifetime
- 1974-12-05 IE IE2512/74A patent/IE40281B1/en unknown
- 1974-12-05 CH CH1619674A patent/CH605679A5/xx not_active IP Right Cessation
- 1974-12-05 DK DK633374A patent/DK633374A/da unknown
- 1974-12-06 JP JP49141098A patent/JPS5088003A/ja active Pending
- 1974-12-06 FR FR7440004A patent/FR2253736B1/fr not_active Expired
- 1974-12-06 SE SE7415305A patent/SE7415305L/xx not_active Application Discontinuation
- 1974-12-06 GB GB5298774A patent/GB1464938A/en not_active Expired
- 1974-12-06 BE BE151258A patent/BE823064A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
DK633374A (fr) | 1975-07-21 |
DE2360794C2 (de) | 1984-12-06 |
FR2253736B1 (fr) | 1978-09-15 |
GB1464938A (en) | 1977-02-16 |
US3960830A (en) | 1976-06-01 |
IE40281L (en) | 1975-06-06 |
NL7415602A (nl) | 1975-06-10 |
CH605679A5 (fr) | 1978-10-13 |
IE40281B1 (en) | 1979-04-25 |
SE7415305L (fr) | 1975-06-09 |
DE2360794A1 (de) | 1975-06-26 |
LU71415A1 (fr) | 1976-11-11 |
FR2253736A1 (fr) | 1975-07-04 |
JPS5088003A (fr) | 1975-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE823064A (fr) | Procede de preparation de peptides | |
BE817682A (fr) | Procede de preparation de microcapsules | |
BE815604A (fr) | Procede de preparation de microcapsules | |
BE813094A (fr) | Procede de preparation de polyester-polyols | |
BE811072A (fr) | Procede de preparation de spath-fluor synthetique | |
BE822059A (fr) | Procede de preparation de polyisocyanates | |
BE815868A (fr) | Procede de preparation de dihydro-3 | |
BE812537A (fr) | Procede de preparation de paraxylene | |
BE817266A (fr) | Procede de preparation de cephalexine | |
FR2291194A1 (fr) | Procede de preparation de nicotinitrile | |
BE822646A (fr) | Procede de preparation de poly-n-alkyliminoalanes | |
BE823317A (fr) | Procede de preparation de beta-chloroethyl-methyl-dichlorosilane | |
BE813908A (fr) | Procede de preparation de la 5-chloro-2-toluidine | |
BE810435A (fr) | Procede de preparation de senarmontite | |
BE820257A (fr) | Procede | |
BE820401A (fr) | Procede de preparation de p-benzoquinone | |
RO64480A (fr) | Procede de preparation de la pyridinecarboxamidosulfoniluree | |
BE821895A (fr) | Procede de preparation de 4-amino-diphenylamine | |
BE816766A (fr) | Procede de preparation de zeaxanthine | |
BE820475A (fr) | Procede de preparation de 6-demethyl-6-desoxy-6-methylene-tetracyclines | |
BE816033A (fr) | Procede de preparation de 2-vinyl-oxazolines | |
BE822218A (fr) | Procede de preparation de 2 | |
BE817556A (fr) | Procede de preparation de manebe colore | |
BE820476A (fr) | Procede de preparation de alpha-6-desoxytetracyclines | |
BE813672A (fr) | Procede de preparation de trimethylbenzoquinone |